Extracting thermo-labile botanicals without leaving behind trace volatile organic compounds (VOCs) or chemical solvents is a constant headache for cosmetic chemists. Traditional extraction often degrades sensitive bio...
Extracting thermo-labile botanicals without leaving behind trace volatile organic compounds (VOCs) or chemical solvents is a constant headache for cosmetic chemists. Traditional extraction often degrades sensitive bio-actives or leaves unwanted chemical residues, forcing formulation teams to compromise between active potency and clean-label standards.
BASF’s Floragenist™ platform bypasses this dilemma entirely. By replacing synthetic glycols with isotonic *Cocos nucifera* (coconut) liquid endosperm, BASF uses a solvent-free extraction technique that preserves delicate phyto-compounds while delivering hard clinical metrics—including a 52% reduction in transepidermal water loss (TEWL).
Instead of relying on harsh synthetic solvents, the Floragenist platform uses eutectic solubilisation within a natural coconut water matrix. This gentle process captures thermo-labile polyphenols and flavonoids in their native, highly bioavailable states without applying damaging heat.
Beyond green extraction, the platform works through targeted epigenetic pathways:
MicroRNA Tuning: It tunes microRNA expression to boost the synthesis of key cell envelope proteins like Filaggrin and Loricrin.
Tight-Junction Integrity: Upregulates Claudin-1 to lock in moisture and reinforce epidermal cohesion.
Endogenous Lipid Synthesis: Triggers the skin's natural lipid production for lasting barrier strength rather than relying on heavy topical occlusion.
Anti-Inflammatory Response: Quiets stress pathways activated by harsh surfactants and environmental aggressors.
Human clinical testing highlights how effectively the Floragenist range restores compromised skin barriers and restores skin radiance.
Formulated at a low 0.1% dosage, Floragenist Blossom counters surfactant-induced barrier damage. In *in vivo* clinical trials, it achieved a 52% reduction in TEWL variation, rapidly rebuilding compromised stratum corneum integrity after SLS/SLES exposure.
At a 0.4% inclusion level, Floragenist Rose addresses sub-clinical inflammation and dull tone. VISIA instrumental analysis showed:
2.7x increase in skin luminosity, improving light reflection across the skin surface.
22% reduction in micro-erythema, soothing underlying vascular reactivity and redness.
For formulation chemists and contract manufacturers, this active platform fits easily into standard batch protocols:
Solubility: Completely water-soluble, making it ideal for crystal-clear serums, essences, and toners.
Cold Processing: Fully cold-process compatible, reducing energy consumption and shortening manufacturing cycles.
pH Flexibility: Remains stable across a skin-friendly pH range of 4.5 to 6.5.
Target Formulations: Suited for barrier-repair gels, post-dermatological treatment care, microbiome-friendly lines, and clean micro-emulsions.
For Indian D2C brands and CDMOs, ingredient selection must balance clinical performance with straightforward compliance under the Cosmetics Rules 2020.
Because there are no synthetic solvents involved, R&D teams can skip ICH Q3C residual solvent testing entirely—simplifying your CDSCO registration dossiers and cutting analytical testing overhead. This solvent-free profile eliminates a major regulatory roadblock and helps speed up domestic launch timelines.
At the same time, coconut liquid endosperm brings immediate recognition to Indian formulations. By pairing an upcycled botanical matrix with verifiable epigenetic science, brands can build a clean narrative around barrier repair and post-procedure recovery that resonates with modern consumers.
Adopting solvent-free active platforms gives Indian manufacturers a clear edge: global-grade clinical claims combined with a streamlined path through local regulations. By switching to bio-identical extraction systems like Floragenist, R&D teams can deliver proven barrier recovery without adding complexity to the bench.
Pairing bio-fermentation with green synthesis offers a practical fix for these traditional formulation bottlenecks. By wrapping bio-fermented actives inside biomimetic nanocarriers, formulators can drive deep dermal a...
The European Commission is officially walking back strict limits previously outlined under Omnibus VIII (Regulation EU 2026/78) for micron-sized silver (CI 77820). Following a comprehensive safety reassessment by the...
